|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1998-8-18
|
|
pubmed:abstractText |
We studied serum N-terminal atrial natriuretic peptide (NT-ANP) in children during and after chemotherapy for cancer to determine its applicability in detecting cardiac dysfunction. Forty-three patients were receiving chemotherapy for malignancy. Forty-eight patients were off chemotherapy and survived between 0.9 and 13 (median 5) years after the diagnosis, receiving cumulative anthracycline doses between 0 and 600 (median 225) mg/m2.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0098-1532
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
73-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9680930-Adolescent,
pubmed-meshheading:9680930-Antibiotics, Antineoplastic,
pubmed-meshheading:9680930-Atrial Natriuretic Factor,
pubmed-meshheading:9680930-Cardiovascular System,
pubmed-meshheading:9680930-Child,
pubmed-meshheading:9680930-Child, Preschool,
pubmed-meshheading:9680930-Daunorubicin,
pubmed-meshheading:9680930-Doxorubicin,
pubmed-meshheading:9680930-Echocardiography,
pubmed-meshheading:9680930-Electrocardiography,
pubmed-meshheading:9680930-Female,
pubmed-meshheading:9680930-Humans,
pubmed-meshheading:9680930-Infant,
pubmed-meshheading:9680930-Male,
pubmed-meshheading:9680930-Predictive Value of Tests
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Serum N-terminal atrial natriuretic peptide (NT-ANP) in the cardiac follow-up in children with cancer.
|
|
pubmed:affiliation |
Department of Pediatrics, Kuopio University Hospital, Finland. Tero.Tikanoja@kuh.fi
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
